PharmaSGP Holding ROE 2024

PharmaSGP Holding Aktienanalyse

What does PharmaSGP Holding do?

PharmaSGP Holding SE is a leading European company specializing in the marketing of over-the-counter and natural pharmaceuticals. The company was founded in 2009 and is headquartered in Gräfelfing near Munich. The history of PharmaSGP began with the vision of founder and CEO Alexander Kurz, who believed that many people were looking for natural alternatives to pharmaceuticals. Kurz founded PharmaSGP with the goal of developing natural health products that help people improve their health and well-being. PharmaSGP's business model focuses on the marketing of over-the-counter and natural pharmaceuticals through pharmacies, drugstores, and online sales. The company has a strong presence in Europe and is also expanding into other regions worldwide. PharmaSGP is divided into three divisions: Consumer Healthcare, Medical Devices, and Healthcare Services. The Consumer Healthcare division offers natural health products and dietary supplements targeting consumers. The company has developed a wide range of products specifically tailored to the needs of people at different stages of life, from pregnancy and breastfeeding to old age. In the field of medical devices, PharmaSGP focuses on the development and marketing of innovative medical devices and technologies tailored to the needs of healthcare professionals. The company has developed a range of medical devices such as medication dispensers or blood glucose meters to facilitate disease treatment. In the Healthcare Services division, the company also offers services such as medical consulting and patient management. This involves holistic patient care, offering various services to ensure effective and comprehensive treatment. PharmaSGP also has an impressive range of products covering various health areas. There are products for dietary supplementation, sleep support, pain therapy, and cold relief, to name just a few. One of PharmaSGP's most well-known products is Yokebe, a natural meal replacement that can help reduce weight. The company is committed to ensuring the quality of its products and therefore works closely with scientists and healthcare professionals to ensure that all products are based on current scientific knowledge and studies. In summary, PharmaSGP is an innovative company focused on the marketing of natural and over-the-counter pharmaceuticals. It has developed a wide range of products and services specifically tailored to the needs of consumers and healthcare professionals. The company is committed to continuously improving the quality of its products and services and works closely with scientists and healthcare professionals to ensure comprehensive patient care. PharmaSGP Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding PharmaSGP Holding's Return on Equity (ROE)

PharmaSGP Holding's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing PharmaSGP Holding's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

PharmaSGP Holding's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in PharmaSGP Holding’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about PharmaSGP Holding stock

What is the ROE (Return on Equity) of PharmaSGP Holding this year?

The ROE of PharmaSGP Holding this year is 0.41 undefined.

How has the Return on Equity (ROE) of PharmaSGP Holding developed compared to the previous year?

The ROE of PharmaSGP Holding has increased by 7.3% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of PharmaSGP Holding?

A high ROE indicates that PharmaSGP Holding generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of PharmaSGP Holding?

A low ROE can indicate that PharmaSGP Holding is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of PharmaSGP Holding affect the company?

A change in ROE (Return on Equity) of PharmaSGP Holding can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of PharmaSGP Holding?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of PharmaSGP Holding?

Some factors that can influence PharmaSGP Holding's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does PharmaSGP Holding pay?

Over the past 12 months, PharmaSGP Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PharmaSGP Holding is expected to pay a dividend of 0.59 EUR.

What is the dividend yield of PharmaSGP Holding?

The current dividend yield of PharmaSGP Holding is .

When does PharmaSGP Holding pay dividends?

PharmaSGP Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of PharmaSGP Holding?

PharmaSGP Holding paid dividends every year for the past 0 years.

What is the dividend of PharmaSGP Holding?

For the upcoming 12 months, dividends amounting to 0.59 EUR are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is PharmaSGP Holding located?

PharmaSGP Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von PharmaSGP Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of PharmaSGP Holding from 7/1/2024 amounting to 1.36 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did PharmaSGP Holding pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of PharmaSGP Holding in the year 2023?

In the year 2023, PharmaSGP Holding distributed 0.45 EUR as dividends.

In which currency does PharmaSGP Holding pay out the dividend?

The dividends of PharmaSGP Holding are distributed in EUR.